The company will expand its health benefits management offerings, as well as make investments in data analytics and innovative health tech
The first in a new drug class of phosphodiesterase‐4D allosteric inhibitors developed by Tetra Therapeutics is well tolerated and helps improve cognition in people with fragile X syndrome, show results from a Phase II trial.
The FDA has approved Myriad Genetics’ myChoice CDx as a companion diagnostic for Zejula (niraparib) to identify women with advanced ovarian cancer in the...
Thermo Fisher Scientific said today it will develop a companion diagnostic for Eli Lilly’s Phase I/II cancer candidate LOXO-292 (selpercatinib) through a collaboration whose...
U.K. research shows that the inflammatory bowel disease drug infliximab stops the body’s immune system from mounting a strong antibody response to the SARS-CoV-2 virus, which may result in these patients being more susceptible to prolonged or repeat cases of COVID-19 and could mean they also have a weaker response to vaccination.
According to Myriad, it is the first and only genetic test approved by the FDA as a CDx designed to help identify patients with metastatic pancreatic cancer who have a germline BRCA mutation and are candidates for treatment with Lynparza.
When the researchers suppressed those genes in mouse models of glaucoma they were able to regenerate the damaged axons. The findings could eventually lead to developing therapies for patients of stroke, spinal cord damage, or traumatic brain injuries—avenues that don't currently exists.
Combining wearable devices, handheld devices and digital apps lets researchers tell the difference between people with early dementia and those without it.
Semen could be considered a liquid biopsy of the organs of male reproductive system—specifically, of the prostate gland. This is convenient. Semen is, potentially,...
Promega’s MSI testing is designed to functionally measure the genomic accumulation of insertion or deletion (INDEL) errors caused by a deficient mismatch-repair system (dMMR) that occurs in certain types of solid tumors.
The study's authors suggested their work could lead to a combination antiviral therapy for COVID-19, which could be especially helpful to unvaccinated people who become infected and to vaccinated people who experience waning immunity.
The vaccine also showed potential for reducing transmission of the virus, with researchers finding a 67% reduction in positive swabs obtained from volunteers in the U.K. arms of the trials following the first dose.
Later this year, combined company plans to launch QIAstat-Dx, designed for use in oncology and respiratory or gastrointestinal infections
DNA methylation could improve outcomes via more accurate diagnoses of indolent or aggressive tumors requiring different treatment regimens
Nodify CDT™ is designed to identify tumors at high risk of turning cancerous and complements another of Biodesix’s clinical assays, Nodify XL2™. Nodify XL2 is designed to help identify lung nodules with a very low risk of cancer. Having one test determine if a patient is low risk and another to determine high risk will help physicians move patients quickly to a definitive care plan.
New research suggests that the antidepressant paroxetine could represent the first-ever disease-modifying treatment for osteoarthritis, and also indicates that other compounds that counteract abnormal activity in cartilage-maintaining cells could be repurposed into therapies for the disease.
From polygenic risk scores and CRISPR to immune therapies and mapping human cells, our inaugural selection of young scientists underscores the breadth of precision health research.
According to Seven Bridges, ARIA addresses what the company says is a lack of tools available in the market that allow easy interoperability of disparate data at this scale.
Edward Abrahams, Ph.D., has been president of the Personalized Medicine Coalition (PMC) since its founding in late 2004. After serving as an anchor partner...
Among the study participants, a single dose resulted in a four-fold increase in antibodies to the SARS-CoV-2 virus spike protein in 95% of participants at Day 28 after injection, the researchers reported.
The genomes of 100,000 people will be sequenced during the first phase of Abu Dhabi’s Population Genome Program, an initiative designed to promote personalized medicine by applying insights to healthcare.
MIT researchers hope that new research findings may lead to clinical studies of the dietary supplement choline specifically in people who carry the APOE4 gene, to see if the supplement could help to reduce the incidence of Alzheimer’s disease.
The Yale research team discovered the variants through an analytically “enhanced” genome-wide association study of more than 1,700 patients whose data was included in the UK Biobank.
Despite questions that surround the use of CRISPR gene editing technology, public and private therapeutics developers continue to raise cash
The researchers performed deep sequencing of both circulating cfDNA and of white blood cells to look for mutations. Subtracting the white blood cells’ information from cfDNA yielded data investigators could use to predict cancer recurrence within nine weeks following preoperative treatment and surgery.